CellCentric is a clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. For more information, visit cellcentric.com. Patient Support Visit Support Site
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
A biopharmaceutical company committed to improving the lives of patients living with rare diseases. Please visit https://www.yourcatalystpathways.com/
Zydus Pharmaceuticals (USA) Inc. is a division of Zydus Lifesciences Limited, a global healthcare provider for over 70 years. Address: 73 Route 31 North Pennington, NJ 08534 Phone: 609-790-1900 Email: customerservice@zydususa.com Website: https://zydususa.com/
Celcuity is a clinical-stage biotechnology company focused on developing a better way to address cellular abnormalities that drive tumor growth. Our teams of drug development scientists, biochemists, and molecular biologists are working to advance new targeted therapies for cancers involving the PAM (PI3K/AKT/mTOR) pathway. This pathway plays a critical role as biological driver of a…
Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market. Founded on the belief that immunotherapy made from a patient’s own cells will transform disease treatment, Dendreon has worked tirelessly to make the fight against cancer personal. Our flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy to…
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s…
Northstar by BillionToOne is a blood-based liquid biopsy platform that delivers ultra-sensitive genomic and methylation analysis to support personalized cancer care. Powered by proprietary QCT™ technology, Northstar Select® provides comprehensive genomic profiling to guide therapy selection, while Northstar Response® enables real-time monitoring of treatment efficacy through tumor-specific methylation tracking. Together, they offer a seamless, non-invasive…
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full…
Sumitomo Pharma America (SMPA) is deeply committed to accelerating scientific and therapeutic breakthroughs to support patient-first outcomes in areas of critical need, including psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA aims to address a wide range of indications where treatment options remain limited or nonexistent. By doing…
Geron is a biopharmaceutical company focused on development and commercialization of therapies in hematologic malignancies. Geron aims to deliver on our mission of changing lives by changing the course of blood cancers. Prescribing Information: https://www.geron.com/medicines/ HCP website: www.rytelohcp.com Patient support programs: https://www.rytelohcp.com/patient-support-program Distributor Network and billing and coding guide. https://www.rytelohcp.com/how-to-order Medical Information Hub: 1-855-437-6664 (1-855-GERONMI) To Report Suspected Adverse Reactions…
Immunocore, LLC is a pioneering, commercial-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infectious and autoimmune diseases.
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted…
Oncocyte is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
At Sobi North America, we are committed to delivering treatment options for patients with Immune thrombocytopenia (ITP), a rare autoimmune disease affecting platelet production and characterized by fatigue, bruising and bleeding. Today, there is increased awareness of the available treatment options, and better life may be possible for people living with ITP.Our portfolio also addresses…
PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, the company aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003, the company is now expanding its global…
About Us AVEO Oncology (“AVEO”) is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients’ lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. (“LG Chem”), establishing a U.S. commercial presence for LG Chem and expanding LG Chem’s global oncology portfolio. AVEO continues to commercialize FOTIVDA® (tivozanib) in…
HUTCHMED is an innovative, global, biopharmaceutical company committed to the discovery and development of targeted oncology therapies, inclusive of neuroendocrine tumors.
ADC Therapeutics. Confronting cancer with the full potential of our science. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs. ADC Therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Visit…
We believe that the best solution for patients may not lie in a single drug but in a unique combination of medicines. TG Therapeutics was founded with one goal in mind—to leverage scientific advances in B-cell biology to develop novel treatments for patients. We’ve dedicated ourselves to this simple concept and to the study of…
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. MI Exome™…
LIBTAYO Surround Product Website CSCC Study Results CSCC Patient Examples Patient Resources
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to…
Blue Earth Diagnostics, a subsidiary of Bracco Imaging S.p.A., is a recognized leader in the development and commercialization of novel PET radiopharmaceuticals to inform clinical management and guide care for cancer patients in areas of unmet medical need. Formed in 2014, Blue Earth Diagnostics is led by proven experts in nuclear medicine, who have expanded…
About Oncopeptides Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. In 2000, the Company was formed by some of Sweden’s most leading scientists with ties preeminent oncology research institutions. Oncopeptides’ headquarters is in Stockholm, Sweden with a U.S. headquarters in Boston, Massachusetts. In addition to Boston, Oncopeptides…
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from…
Gilead, is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping people with hard-to-treat cancers. The impossible is simply what hasn’t been achieved yet. Gilead’s research and development program is focused on what’s next. Their goal is to discover, identify and evaluate investigational compounds that show potential to advance the treatment of…
About Blueprint Medicines, a Sanofi Company Blueprint Medicines, a Sanofi company, is a global, fully integrated biopharmaceutical company that seeks to invent life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep…
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform…
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the…
Epizyme’s vision is to rewrite treatment for cancer and other serious diseases through novel epigenetic medicines. Epizyme aspires to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action. Learn more Epizyme.com. Patient Assistance & Product Support: EpizymeNOW 1-833-4EPI(NOW) (437-4669)
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies…
MorphoSys is a clinical stage biopharmaceutical company headquartered in Munich, Germany. MorphoSys is dedicated to the discovery, development and commercialization of exceptional, innovative therapies for patients suffering from serious diseases. The focus is on cancer. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed…
Website: https://beonemedicines.us/ Patient Support: https://www.mybeonesupport.com/ BeOne Medicines is a global oncology company discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company…
Natera has developed Signatera, a personalized ctDNA test for molecular residual disease (MRD) detection and recurrence monitoring in patients previously diagnosed with cancer. Signatera’s tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence with longer lead times. Signatera has been clinically validated in multiple cancer types…
Rare diseases aren’t just in our name: they are at the core of all that we do. We work side-by-side with rare disease communities to raise awareness, educate, and advocate for improved diagnosis. Together, we can celebrate our successes and strengthen our impact for people living with rare diseases. Learn More: https://sylvant.com/understanding-imcd/what-is-imcd/ Learn More:…
Company Overview Stemline Therapeutics, Inc. (“Stemline”) a wholly-owned subsidiary of the Menarini Group, is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. Our dedicated team of scientists, specialists, researchers, and developers are committed to providing transformational oncology treatments to those who need it, with the ultimate goal of improving…
Coherus Oncology is focused on developing and commercializing a diversified portfolio of immuno-oncology therapies. The advancement of multiple clinical stage candidates underscores our commitment to immuno-oncology treatments while the biosimilar business enables us to provide better access to therapy for patients with life-altering illnesses. About Coherus Solutions™ Coherus Oncology is committed to supporting patients with…
Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer – single-minded in our resolve to deliver new therapies that not only keep cancer at bay, but…
Rigel Pharmaceuticals, Inc. is a South San Francisco-based biopharmaceutical company focused on discovering, developing, and providing novel therapies that enhance the lives of people with immune and hematological disorders, cancers, and rare diseases. Rigel’s clinical development programs span multiple disease targets including chronic immune thrombocytopenia, autoimmune hemolytic anemia and others. Rigel’s first FDA approved product…
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has an approved oncology precision medicine and multiple first-in-class investigational therapies in clinical and/or preclinical…
Sun Pharma is a leading global pharmaceutical company, providing high-quality medicines trusted by patients. Every day, we help millions of Americans through our diverse portfolio of Innovative Medicines, Generics and Consumer Healthcare products. Our local manufacturing and distribution enables delivery of high-quality therapies that meet the highest regulatory standards. UNLOXCYT SUPPORT is here to…
Puma Biotechnology focus is on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune® – the TTFields delivery system for glioblastoma (GBM) – was launched in the U.S. for the treatment of recurrent…
EMD Serono is a science-led organization of curious minds dedicated to delivering transformative medicines that can make a difference in the lives of people affected by cancer. We apply our scientific curiosity to tackling challenging tumor types in key areas—gastrointestinal (GI), genitourinary (GU), and thoracic cancers—where there are unmet needs and where we believe we…
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Click here to listen to Dr. Santos, FLASCO Secretary, discuss the role of liquid biopsy in NSCLC. Dr. Santos shares his experience using Guardant360 in clinical practice, including his perspective…
About Adaptive Biotechnologies Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it…
Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. Kite has the largest in-house cell therapy manufacturing network in the world,…
Founded in 1994, Exelixis is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. Visit our website to learn more. https://www.exelixis.com.
Biotheranostics, Inc. represents the oncology portfolio within the Diagnostic Solutions division of Hologic, Inc. The CLIA certified, CAP accredited laboratory provides two proprietary, highly differentiated molecular diagnostic tests for breast and metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID, respectively. Breast Cancer Index (BCI) Breast Cancer Index (BCI) is the only genomic test recognized…
At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge technologies, and by working together with our partners – scientists, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in…
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well…
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs are targeted at specific subsets of cancer, combining personalized medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
OVERVIEW Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines. Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value…
For more information about Pharmacyclics LLC, an AbbVie Company, please visit pharmacyclics.com.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products…
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. With our leading-edge processes in manufacturing, strong pipeline of treatments and reliable supply, we strive to improve patient access to more affordable,…
Taiho Oncology, Inc., a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works urgently to develop innovative cancer treatments. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the…
Overview We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to…
GSK Oncology’s mission and purpose is to deliver potentially transformative medicines and industry-leading programs that provide enduring impact and hope for our patients and their loved ones. For more information, please visit Together With GSK Oncology Get an inside look at ZEJULA and browse our collection of videos to learn how it may help appropriate…
Company Overview Patient Assistance Programs Overview AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly-growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. With at least six new medicines to be launched between 2014 and 2020, and a broad pipeline of small molecules and biologics…
Founded in 2018, Acrotech Biopharma Inc. was formed as a global platform to commercialize innovative proprietary medications. The company aims to launch scientifically advanced products to address unmet needs and deliver value to patients as well as all healthcare stakeholders. Acrotech aspires to be a patient focused, research-based organization that strives to launch treatments which…
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we focus our resources, investments and energy on discovering, developing and commercializing medicines in three key therapeutic areas – Oncology, Rare Disease and Neuroscience. We are dedicated to providing hope for patients whose lives are challenged by unmet medical needs. Our…
Overview At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer from multiple angles, including small molecules, antibody-drug conjugates (ADCs), and bispecific antibodies, including other immune-oncology biologics. We are focused on delivering transformative therapies in…
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and…
Company Overview Patient Assistance Programs Contact Info Overview COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE Celgene seeks to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the…
Products, People and Programs Making a Difference For over 150 years Bayer has been an innovation company rooted in science. Our presence in the U.S. harkens back to the mid-19th century as a chemical company making dyes in Albany, NY. However, by the late-19th century we moved into the healthcare field with the introduction of…
© 2021 FLASCO | Premium Website Design by The HDG
